Starpharma Holdings LimitedASX: SPL

AstraZeneca DEP Bcl2/xL inhibitors show compelling efficacy

Aug 31, 2018 at 4:21 AM UTC · Issued by Starpharma Holdings Limited

Starpharma Holdings Ltd has released a press release.

View Attachment